跳至主要内容
临床试验/NCT03180164
NCT03180164Unknown不适用

Anxiety and Depression in Chronic Airways Diseases

Assiut University0 个研究点目标入组 1 人开始时间: 2018年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1
主要终点
compare anxiety and depression in different forms of chronic lung diseases

研究概览

简要总结

Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment .

Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety.

Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'

详细描述

This fear and sense of helplessness can lead to panic and evidence suggests that patients with chronic breathlessness often call for emergency assistance during the night According to GOLD report 2017, anxiety and depression in chronic obstructive pulmonary disease patients are both associated with poor prognosis.

Much of the evidence explored so far relates to chronic obstructive pulmonary disease. While other chronic lung diseases have received less attention In addition to, several studies have been found relationship between asthma and psychological disturbance .One review of literature describes an increased prevalence of psychological co-morbidity in asthmatic adults and another research suggests that anxiety and depression are more common in patients with moderate to severe asthma than in the general population Gift. found significantly greater self-reported depression scores among patients with chronic obstructive pulmonary disease receiving prednisone compared to patients not receiving any steroids.

Interestingly, the psychiatric sequel of steroid treatment are often sudden in onset and appear to generally occur within 2 weeks after steroid introduction

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis

排除标准

  • Diabetes Mellitus and Hypertension.
  • Cardiac diseases.
  • Chronic renal and liver diseases.

研究组 & 干预措施

chronic lung diseases

Other

bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale

干预措施: hospital anxiety and depression scale (Other)

结局指标

主要结局

compare anxiety and depression in different forms of chronic lung diseases

时间窗: 10 minutes

by hospital anxiety and depression scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

fareda ahmed mohamed

principle investigator

Assiut University

相似试验